# EC_number_0048: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/EC_number_0048.txt)

**Task:** `EC_number`  
**Author key, unchanged:** **B** — 1.5.1.38

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |
| after | GPT-6 Luna | supported | reasoning-supported | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MSTYGTLLKVTSYGESHGKAIGCVIDGFLSNIEINFDLIQKQLDRRRPNQSKLTSNRNEKDKLVILSGFDENKTLGTPITFLIYNEDIKKEDYNSFINIPRPGHGDYTYFMKYHVKNKSGSSRFSGRETATRVAAGACIEQWLYKSYNCSIVSYVHSVGNIKIPEQVSKELENKNPPSRDLVDSYGTVRYNEKEKIFMDCFNRIYDMNASMLKTDEYNKNTLTIPSIDNTYINVKTNECNINQVDNNHNNYINDKDNTFNNSEKSDEWIYLQTRCPHPYTAVQICSYILKLKNKGDSVGGIATCIIQNPPIGIGEPIFDKLEAELAKMILSIPAVKGIEFGSGFNGTYMFGSMHNDIFIPVENMSTKKESDLLYDDKGECKNMSYHSTIQNNEDQILNSTKGFMPPKNDKNFNNIDDYNVTFNNNEEKLLITKTNNCGGILAGISTGNNIVFRSAIKPVSSIQIEKETSDFYGNMCNLKVQGRHDSCILPRLPPIIEASSSMVIGDLILRQISKYGDKKLPTLFRNM

[Multiple Choices]
A. 1.5.1.32
B. 1.5.1.38
C. 5.6.2.4
D. 3.2.2.5
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Enzyme Commission (EC) Number Prediction, which is to predict the complete 4-digit Enzyme Commission (EC) number for a given protein. The EC number is a numerical classification that categorizes enzymes based on the chemical reactions they catalyze. You should select the most accurate EC number from the provided options based on the protein's sequence.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches the Plasmodium falciparum UniProt entry, which annotates EC 1.5.1.38 and cites experimental evidence for that activity. The historical entry available by the stated cutoff also includes this annotation. The evidence supports B, though it does not establish that this is the protein’s only EC activity.

Citations as saved: [C1](#evidence-c1), [C6](#evidence-c6), [H2](#evidence-h2), [H6](#evidence-h6).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence alone does not provide a defensible way to distinguish the specific FMN-reductase activity represented by 1.5.1.38 from the other precise EC choices.


**Missing item-specific fact**

> The protein-specific experimentally characterized reaction—FMNH2 + NADP(+) = FMN + NADPH + 2 H(+)—or an equivalent annotation is needed to justify EC 1.5.1.38.


**Reason**

> Inferring a broad enzyme family from sequence would not establish this specific catalytic activity or its complete EC number; doing so depends on an item-specific annotation or experimental fact absent from the question.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Among the listed choices, the evidence supports B. However, the protein is also annotated with EC 4.2.3.5, which is not offered, so the single-answer format does not capture all annotated catalytic activities.


### Important caveats

- The UniProt record is for Plasmodium falciparum isolate 3D7, and the supplied sequence matches its sequence.
- The cited UniProt evidence for EC 1.5.1.38 is experimental evidence, but the primary paper was not independently reviewed here.
- The author’s exact source snapshot is unknown; a historical matched entry available by the stated cutoff also supports the key.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence alone does not provide a defensible way to distinguish the specific FMN-reductase activity represented by 1.5.1.38 from the other precise EC choices.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific experimentally characterized reaction—FMNH2 + NADP(+) = FMN + NADPH + 2 H(+)—or an equivalent annotation is needed to justify EC 1.5.1.38.",
    "reason": "Inferring a broad enzyme family from sequence would not establish this specific catalytic activity or its complete EC number; doing so depends on an item-specific annotation or experimental fact absent from the question."
  },
  "case_id": "EC_number_0048",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C6",
      "H2",
      "H6"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches the Plasmodium falciparum UniProt entry, which annotates EC 1.5.1.38 and cites experimental evidence for that activity. The historical entry available by the stated cutoff also includes this annotation. The evidence supports B, though it does not establish that this is the protein’s only EC activity."
  },
  "important_caveats": [
    "The UniProt record is for Plasmodium falciparum isolate 3D7, and the supplied sequence matches its sequence.",
    "The cited UniProt evidence for EC 1.5.1.38 is experimental evidence, but the primary paper was not independently reviewed here.",
    "The author’s exact source snapshot is unknown; a historical matched entry available by the stated cutoff also supports the key."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the listed choices, the evidence supports B. However, the protein is also annotated with EC 4.2.3.5, which is not offered, so the single-answer format does not capture all annotated catalytic activities."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "EC_number_0048",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the Plasmodium falciparum UniProt entry, which annotates EC 1.5.1.38 and cites experimental evidence for that activity. The historical entry available by the stated cutoff also includes this annotation. The evidence supports B, though it does not establish that this is the protein’s only EC activity.",
    "evidence_ids": ["C1", "C6", "H2", "H6"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence alone does not provide a defensible way to distinguish the specific FMN-reductase activity represented by 1.5.1.38 from the other precise EC choices.",
    "missing_item_specific_fact": "The protein-specific experimentally characterized reaction—FMNH2 + NADP(+) = FMN + NADPH + 2 H(+)—or an equivalent annotation is needed to justify EC 1.5.1.38.",
    "reason": "Inferring a broad enzyme family from sequence would not establish this specific catalytic activity or its complete EC number; doing so depends on an item-specific annotation or experimental fact absent from the question."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the listed choices, the evidence supports B. However, the protein is also annotated with EC 4.2.3.5, which is not offered, so the single-answer format does not capture all annotated catalytic activities."
  },
  "important_caveats": [
    "The UniProt record is for Plasmodium falciparum isolate 3D7, and the supplied sequence matches its sequence.",
    "The cited UniProt evidence for EC 1.5.1.38 is experimental evidence, but the primary paper was not independently reviewed here.",
    "The author’s exact source snapshot is unknown; a historical matched entry available by the stated cutoff also supports the key."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry C6KT66 (AROC_PLAF7, chorismate synthase from P. falciparum) is annotated with EC 1.5.1.38 (FMNH2 + NADP(+) = FMN + NADPH + 2 H(+)) with direct experimental evidence (ECO:0000269, PubMed:31381947, Khera et al. 2019 'Chorismate synthase from malaria parasites is bifunctional enzyme'). The sequence matches exactly (SHA256 confirmed). Among the four options, only 1.5.1.38 is annotated for this protein; 4.2.3.5 (the primary chorismate synthase activity) is absent from the choices, making B the only supported answer.

Citations as saved: [C4](#evidence-c4), [C6](#evidence-c6), [C8](#evidence-c8), [H2](#evidence-h2), [H6](#evidence-h6).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> A model recognizing the sequence as chorismate synthase (a well-known shikimate-pathway enzyme) would predict EC 4.2.3.5 as the primary activity, which is NOT among the options. Identifying the secondary FMN reductase activity (EC 1.5.1.38) requires knowing the specific 2019 experimental finding that P. falciparum chorismate synthase is bifunctional. While chorismate synthase uses FMN as a cofactor, this does not logically imply it catalyzes FMNH2 + NADP(+) → FMN + NADPH; that is a distinct oxidoreductase reaction demonstrated experimentally for this particular protein.


**Missing item-specific fact**

> The specific experimental demonstration (PubMed:31381947, 2019) that P. falciparum chorismate synthase possesses a secondary FMN reductase (NADPH) activity corresponding to EC 1.5.1.38. This bifunctional property is not inferable from sequence motifs, general chorismate synthase biochemistry, or standard EC classification logic.


**Reason**

> The sequence provides no distinguishing motif that would lead a model to select EC 1.5.1.38 over the other three options through general biological reasoning. The bifunctional nature is an item-specific experimental fact about this particular protein, discovered only in 2019. A model must either memorize this annotation or recognize the exact sequence and recall its database entry.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Although the protein is bifunctional with primary EC 4.2.3.5 and secondary EC 1.5.1.38, only 1.5.1.38 appears among the options. The other three (1.5.1.32, 5.6.2.4, 3.2.2.5) are unrelated enzyme classes with no annotation connection to this protein. Thus B is the uniquely defensible choice despite the question's singular phrasing ('the EC number') for a bifunctional enzyme.


### Important caveats

- The protein's primary and namesake EC number is 4.2.3.5 (chorismate synthase), confirmed by direct assay (ECO:0000269). The question's omission of this from the options effectively forces selection of the secondary activity.
- EC 1.5.1.38 annotation carries evidence code ECO:0000269 (direct assay) from a single publication (PubMed:31381947, 2019), making it relatively recent and specific.
- The bifunctional characterization is specific to Plasmodium falciparum chorismate synthase and is not a general property of chorismate synthases across organisms.
- The question asks for 'the complete 4-digit EC number' (singular) for a protein with two experimentally supported EC numbers, creating a minor framing inconsistency.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "A model recognizing the sequence as chorismate synthase (a well-known shikimate-pathway enzyme) would predict EC 4.2.3.5 as the primary activity, which is NOT among the options. Identifying the secondary FMN reductase activity (EC 1.5.1.38) requires knowing the specific 2019 experimental finding that P. falciparum chorismate synthase is bifunctional. While chorismate synthase uses FMN as a cofactor, this does not logically imply it catalyzes FMNH2 + NADP(+) → FMN + NADPH; that is a distinct oxidoreductase reaction demonstrated experimentally for this particular protein.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The specific experimental demonstration (PubMed:31381947, 2019) that P. falciparum chorismate synthase possesses a secondary FMN reductase (NADPH) activity corresponding to EC 1.5.1.38. This bifunctional property is not inferable from sequence motifs, general chorismate synthase biochemistry, or standard EC classification logic.",
    "reason": "The sequence provides no distinguishing motif that would lead a model to select EC 1.5.1.38 over the other three options through general biological reasoning. The bifunctional nature is an item-specific experimental fact about this particular protein, discovered only in 2019. A model must either memorize this annotation or recognize the exact sequence and recall its database entry."
  },
  "case_id": "EC_number_0048",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C6",
      "C8",
      "H2",
      "H6"
    ],
    "judgment": "supported",
    "reason": "UniProt entry C6KT66 (AROC_PLAF7, chorismate synthase from P. falciparum) is annotated with EC 1.5.1.38 (FMNH2 + NADP(+) = FMN + NADPH + 2 H(+)) with direct experimental evidence (ECO:0000269, PubMed:31381947, Khera et al. 2019 'Chorismate synthase from malaria parasites is bifunctional enzyme'). The sequence matches exactly (SHA256 confirmed). Among the four options, only 1.5.1.38 is annotated for this protein; 4.2.3.5 (the primary chorismate synthase activity) is absent from the choices, making B the only supported answer."
  },
  "important_caveats": [
    "The protein's primary and namesake EC number is 4.2.3.5 (chorismate synthase), confirmed by direct assay (ECO:0000269). The question's omission of this from the options effectively forces selection of the secondary activity.",
    "EC 1.5.1.38 annotation carries evidence code ECO:0000269 (direct assay) from a single publication (PubMed:31381947, 2019), making it relatively recent and specific.",
    "The bifunctional characterization is specific to Plasmodium falciparum chorismate synthase and is not a general property of chorismate synthases across organisms.",
    "The question asks for 'the complete 4-digit EC number' (singular) for a protein with two experimentally supported EC numbers, creating a minor framing inconsistency."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Although the protein is bifunctional with primary EC 4.2.3.5 and secondary EC 1.5.1.38, only 1.5.1.38 appears among the options. The other three (1.5.1.32, 5.6.2.4, 3.2.2.5) are unrelated enzyme classes with no annotation connection to this protein. Thus B is the uniquely defensible choice despite the question's singular phrasing ('the EC number') for a bifunctional enzyme."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "EC_number_0048",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry C6KT66 (AROC_PLAF7, chorismate synthase from P. falciparum) is annotated with EC 1.5.1.38 (FMNH2 + NADP(+) = FMN + NADPH + 2 H(+)) with direct experimental evidence (ECO:0000269, PubMed:31381947, Khera et al. 2019 'Chorismate synthase from malaria parasites is bifunctional enzyme'). The sequence matches exactly (SHA256 confirmed). Among the four options, only 1.5.1.38 is annotated for this protein; 4.2.3.5 (the primary chorismate synthase activity) is absent from the choices, making B the only supported answer.",
    "evidence_ids": ["C4", "C6", "C8", "H2", "H6"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "A model recognizing the sequence as chorismate synthase (a well-known shikimate-pathway enzyme) would predict EC 4.2.3.5 as the primary activity, which is NOT among the options. Identifying the secondary FMN reductase activity (EC 1.5.1.38) requires knowing the specific 2019 experimental finding that P. falciparum chorismate synthase is bifunctional. While chorismate synthase uses FMN as a cofactor, this does not logically imply it catalyzes FMNH2 + NADP(+) → FMN + NADPH; that is a distinct oxidoreductase reaction demonstrated experimentally for this particular protein.",
    "missing_item_specific_fact": "The specific experimental demonstration (PubMed:31381947, 2019) that P. falciparum chorismate synthase possesses a secondary FMN reductase (NADPH) activity corresponding to EC 1.5.1.38. This bifunctional property is not inferable from sequence motifs, general chorismate synthase biochemistry, or standard EC classification logic.",
    "reason": "The sequence provides no distinguishing motif that would lead a model to select EC 1.5.1.38 over the other three options through general biological reasoning. The bifunctional nature is an item-specific experimental fact about this particular protein, discovered only in 2019. A model must either memorize this annotation or recognize the exact sequence and recall its database entry."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Although the protein is bifunctional with primary EC 4.2.3.5 and secondary EC 1.5.1.38, only 1.5.1.38 appears among the options. The other three (1.5.1.32, 5.6.2.4, 3.2.2.5) are unrelated enzyme classes with no annotation connection to this protein. Thus B is the uniquely defensible choice despite the question's singular phrasing ('the EC number') for a bifunctional enzyme."
  },
  "important_caveats": [
    "The protein's primary and namesake EC number is 4.2.3.5 (chorismate synthase), confirmed by direct assay (ECO:0000269). The question's omission of this from the options effectively forces selection of the secondary activity.",
    "EC 1.5.1.38 annotation carries evidence code ECO:0000269 (direct assay) from a single publication (PubMed:31381947, 2019), making it relatively recent and specific.",
    "The bifunctional characterization is specific to Plasmodium falciparum chorismate synthase and is not a general property of chorismate synthases across organisms.",
    "The question asks for 'the complete 4-digit EC number' (singular) for a protein with two experimentally supported EC numbers, creating a minor framing inconsistency."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The supplied sequence matches the UniProt entry, which assigns EC 1.5.1.38 to the FMNH2/NADP+ reaction with experimental evidence. The same protein is also annotated with EC 4.2.3.5 for chorismate synthase activity; that code is not among the choices.

Citations as saved: [C6](#evidence-c6), [H6](#evidence-h6).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence has features consistent with the chorismate-synthase family. Transferable knowledge of related parasite chorismate synthases can support the inference that this family may also catalyze FMN reduction, distinguishing the offered EC 1.5.1.38 (B) from the other choices. This is a specialized family-level inference, not a consequence of chorismate-synthase identity alone.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> A knowledgeable model could use sequence-family recognition and learned functional patterns from related proteins to favor B without recalling this exact protein's annotation. The unusual additional activity makes the inference less certain than identifying the usual chorismate-synthase activity.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The protein has another supported EC annotation, 4.2.3.5, but it is not offered. Among the listed choices, the supplied evidence supports B.


### Important caveats

- The evidence supports B as one activity of a bifunctional enzyme; the prompt's singular wording could obscure that the protein has another EC number.
- The sequence-family inference is probabilistic: generic chorismate-synthase features alone do not establish the additional FMN-reductase activity.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence has features consistent with the chorismate-synthase family. Transferable knowledge of related parasite chorismate synthases can support the inference that this family may also catalyze FMN reduction, distinguishing the offered EC 1.5.1.38 (B) from the other choices. This is a specialized family-level inference, not a consequence of chorismate-synthase identity alone.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "A knowledgeable model could use sequence-family recognition and learned functional patterns from related proteins to favor B without recalling this exact protein's annotation. The unusual additional activity makes the inference less certain than identifying the usual chorismate-synthase activity."
  },
  "case_id": "EC_number_0048",
  "expected_answer_check": {
    "evidence_ids": [
      "C6",
      "H6"
    ],
    "judgment": "supported",
    "reason": "The supplied sequence matches the UniProt entry, which assigns EC 1.5.1.38 to the FMNH2/NADP+ reaction with experimental evidence. The same protein is also annotated with EC 4.2.3.5 for chorismate synthase activity; that code is not among the choices."
  },
  "important_caveats": [
    "The evidence supports B as one activity of a bifunctional enzyme; the prompt's singular wording could obscure that the protein has another EC number.",
    "The sequence-family inference is probabilistic: generic chorismate-synthase features alone do not establish the additional FMN-reductase activity."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The protein has another supported EC annotation, 4.2.3.5, but it is not offered. Among the listed choices, the supplied evidence supports B."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "EC_number_0048",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The supplied sequence matches the UniProt entry, which assigns EC 1.5.1.38 to the FMNH2/NADP+ reaction with experimental evidence. The same protein is also annotated with EC 4.2.3.5 for chorismate synthase activity; that code is not among the choices.",
    "evidence_ids": ["C6", "H6"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence has features consistent with the chorismate-synthase family. Transferable knowledge of related parasite chorismate synthases can support the inference that this family may also catalyze FMN reduction, distinguishing the offered EC 1.5.1.38 (B) from the other choices. This is a specialized family-level inference, not a consequence of chorismate-synthase identity alone.",
    "missing_item_specific_fact": "",
    "reason": "A knowledgeable model could use sequence-family recognition and learned functional patterns from related proteins to favor B without recalling this exact protein's annotation. The unusual additional activity makes the inference less certain than identifying the usual chorismate-synthase activity."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The protein has another supported EC annotation, 4.2.3.5, but it is not offered. Among the listed choices, the supplied evidence supports B."
  },
  "important_caveats": [
    "The evidence supports B as one activity of a bifunctional enzyme; the prompt's singular wording could obscure that the protein has another EC number.",
    "The sequence-family inference is probabilistic: generic chorismate-synthase features alone do not establish the additional FMN-reductase activity."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry C6KT66 (AROC_PLAF7) annotates EC 1.5.1.38 (FMNH2 + NADP+ = FMN + NADPH + 2H+) with experimental evidence (ECO:0000269, PubMed:31381947) as one of two catalytic activities of this bifunctional chorismate synthase from Plasmodium falciparum. The sequence in the question matches the source entry (SHA256 confirmed). The expected answer B (1.5.1.38) is directly supported by the database annotation with experimental evidence codes.

Citations as saved: [C4](#evidence-c4), [C6](#evidence-c6), [H1](#evidence-h1), [H2](#evidence-h2), [H6](#evidence-h6).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains recognizable FMN-binding motifs (e.g., GFDENKTLGTPITFLIYNEDIKKEDYNSFINIPRPGHGDYTYFMKYHVKNKSGSSRFSGRETATRVAAGACIEQWLYKSYNCSIVSYVHSVGNIKIPEQ and GSGFNGTYMFGSMHNDIFIP regions) characteristic of the chorismate synthase family, a well-known FMN-dependent enzyme in the shikimate pathway. Recognition of this flavoprotein family allows elimination of EC 5.6.2.4 (chaperone-like ATPase, requires AAA+ fold absent here) and EC 3.2.2.5 (glycosylase, requires sugar-binding motifs absent here). Between the two remaining oxidoreductase options, EC 1.5.1.38 is specifically FMNH2:NADP+ oxidoreductase — the canonical reoxidation reaction for FMN-dependent enzymes — whereas EC 1.5.1.32 involves a different CH-NH substrate. A model recognizing the FMN-binding character of the protein can infer that the relevant oxidoreductase activity involves FMNH2 as the electron donor, pointing to 1.5.1.38 rather than 1.5.1.32.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The FMN-binding motifs in the sequence are transferable family-level features shared with other chorismate synthases and flavoproteins. The knowledge that FMNH2:NADP+ oxidoreductase is EC 1.5.1.38 is general enzymology. The elimination of 5.6.2.4 and 3.2.2.5 relies on fold recognition. The distinction between 1.5.1.32 and 1.5.1.38, while specific, is addressable by recognizing the FMN cofactor in the sequence and knowing that 1.5.1.38 specifically denotes FMNH2 oxidation by NADP+.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The protein is bifunctional (EC 4.2.3.5 and EC 1.5.1.38), but EC 4.2.3.5 is not among the offered choices. Among the four options, only 1.5.1.38 is annotated for this protein. The other three options (1.5.1.32, 5.6.2.4, 3.2.2.5) are not supported by any annotation or by the sequence's structural features. No multiple defensible options exist among the given choices.


### Important caveats

- The protein is primarily known as chorismate synthase (EC 4.2.3.5, lyase); the oxidoreductase activity (EC 1.5.1.38) is a secondary bifunctional activity discovered in 2019 (PubMed:31381947). The question does not specify which catalytic activity to predict, but since 4.2.3.5 is absent from the choices, this does not create practical ambiguity.
- EC 1.5.1.38 is annotated with evidence code ECO:0000305 (curator inference from literature) for the EC number assignment, while the underlying catalytic activity has ECO:0000269 (direct assay evidence). The distinction between 1.5.1.32 and 1.5.1.38 is highly specific and relies on knowing the exact substrate (FMNH2) for 1.5.1.38.
- The reviewer-only evidence was not available to the evaluated model; the reasoning argument relies solely on sequence motifs and general flavoprotein/chorismate synthase family knowledge.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains recognizable FMN-binding motifs (e.g., GFDENKTLGTPITFLIYNEDIKKEDYNSFINIPRPGHGDYTYFMKYHVKNKSGSSRFSGRETATRVAAGACIEQWLYKSYNCSIVSYVHSVGNIKIPEQ and GSGFNGTYMFGSMHNDIFIP regions) characteristic of the chorismate synthase family, a well-known FMN-dependent enzyme in the shikimate pathway. Recognition of this flavoprotein family allows elimination of EC 5.6.2.4 (chaperone-like ATPase, requires AAA+ fold absent here) and EC 3.2.2.5 (glycosylase, requires sugar-binding motifs absent here). Between the two remaining oxidoreductase options, EC 1.5.1.38 is specifically FMNH2:NADP+ oxidoreductase — the canonical reoxidation reaction for FMN-dependent enzymes — whereas EC 1.5.1.32 involves a different CH-NH substrate. A model recognizing the FMN-binding character of the protein can infer that the relevant oxidoreductase activity involves FMNH2 as the electron donor, pointing to 1.5.1.38 rather than 1.5.1.32.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "The FMN-binding motifs in the sequence are transferable family-level features shared with other chorismate synthases and flavoproteins. The knowledge that FMNH2:NADP+ oxidoreductase is EC 1.5.1.38 is general enzymology. The elimination of 5.6.2.4 and 3.2.2.5 relies on fold recognition. The distinction between 1.5.1.32 and 1.5.1.38, while specific, is addressable by recognizing the FMN cofactor in the sequence and knowing that 1.5.1.38 specifically denotes FMNH2 oxidation by NADP+."
  },
  "case_id": "EC_number_0048",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C6",
      "H1",
      "H2",
      "H6"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry C6KT66 (AROC_PLAF7) annotates EC 1.5.1.38 (FMNH2 + NADP+ = FMN + NADPH + 2H+) with experimental evidence (ECO:0000269, PubMed:31381947) as one of two catalytic activities of this bifunctional chorismate synthase from Plasmodium falciparum. The sequence in the question matches the source entry (SHA256 confirmed). The expected answer B (1.5.1.38) is directly supported by the database annotation with experimental evidence codes."
  },
  "important_caveats": [
    "The protein is primarily known as chorismate synthase (EC 4.2.3.5, lyase); the oxidoreductase activity (EC 1.5.1.38) is a secondary bifunctional activity discovered in 2019 (PubMed:31381947). The question does not specify which catalytic activity to predict, but since 4.2.3.5 is absent from the choices, this does not create practical ambiguity.",
    "EC 1.5.1.38 is annotated with evidence code ECO:0000305 (curator inference from literature) for the EC number assignment, while the underlying catalytic activity has ECO:0000269 (direct assay evidence). The distinction between 1.5.1.32 and 1.5.1.38 is highly specific and relies on knowing the exact substrate (FMNH2) for 1.5.1.38.",
    "The reviewer-only evidence was not available to the evaluated model; the reasoning argument relies solely on sequence motifs and general flavoprotein/chorismate synthase family knowledge."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The protein is bifunctional (EC 4.2.3.5 and EC 1.5.1.38), but EC 4.2.3.5 is not among the offered choices. Among the four options, only 1.5.1.38 is annotated for this protein. The other three options (1.5.1.32, 5.6.2.4, 3.2.2.5) are not supported by any annotation or by the sequence's structural features. No multiple defensible options exist among the given choices."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "EC_number_0048",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry C6KT66 (AROC_PLAF7) annotates EC 1.5.1.38 (FMNH2 + NADP+ = FMN + NADPH + 2H+) with experimental evidence (ECO:0000269, PubMed:31381947) as one of two catalytic activities of this bifunctional chorismate synthase from Plasmodium falciparum. The sequence in the question matches the source entry (SHA256 confirmed). The expected answer B (1.5.1.38) is directly supported by the database annotation with experimental evidence codes.",
    "evidence_ids": ["C4", "C6", "H1", "H2", "H6"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains recognizable FMN-binding motifs (e.g., GFDENKTLGTPITFLIYNEDIKKEDYNSFINIPRPGHGDYTYFMKYHVKNKSGSSRFSGRETATRVAAGACIEQWLYKSYNCSIVSYVHSVGNIKIPEQ and GSGFNGTYMFGSMHNDIFIP regions) characteristic of the chorismate synthase family, a well-known FMN-dependent enzyme in the shikimate pathway. Recognition of this flavoprotein family allows elimination of EC 5.6.2.4 (chaperone-like ATPase, requires AAA+ fold absent here) and EC 3.2.2.5 (glycosylase, requires sugar-binding motifs absent here). Between the two remaining oxidoreductase options, EC 1.5.1.38 is specifically FMNH2:NADP+ oxidoreductase — the canonical reoxidation reaction for FMN-dependent enzymes — whereas EC 1.5.1.32 involves a different CH-NH substrate. A model recognizing the FMN-binding character of the protein can infer that the relevant oxidoreductase activity involves FMNH2 as the electron donor, pointing to 1.5.1.38 rather than 1.5.1.32.",
    "missing_item_specific_fact": "",
    "reason": "The FMN-binding motifs in the sequence are transferable family-level features shared with other chorismate synthases and flavoproteins. The knowledge that FMNH2:NADP+ oxidoreductase is EC 1.5.1.38 is general enzymology. The elimination of 5.6.2.4 and 3.2.2.5 relies on fold recognition. The distinction between 1.5.1.32 and 1.5.1.38, while specific, is addressable by recognizing the FMN cofactor in the sequence and knowing that 1.5.1.38 specifically denotes FMNH2 oxidation by NADP+."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The protein is bifunctional (EC 4.2.3.5 and EC 1.5.1.38), but EC 4.2.3.5 is not among the offered choices. Among the four options, only 1.5.1.38 is annotated for this protein. The other three options (1.5.1.32, 5.6.2.4, 3.2.2.5) are not supported by any annotation or by the sequence's structural features. No multiple defensible options exist among the given choices."
  },
  "important_caveats": [
    "The protein is primarily known as chorismate synthase (EC 4.2.3.5, lyase); the oxidoreductase activity (EC 1.5.1.38) is a secondary bifunctional activity discovered in 2019 (PubMed:31381947). The question does not specify which catalytic activity to predict, but since 4.2.3.5 is absent from the choices, this does not create practical ambiguity.",
    "EC 1.5.1.38 is annotated with evidence code ECO:0000305 (curator inference from literature) for the EC number assignment, while the underlying catalytic activity has ECO:0000269 (direct assay evidence). The distinction between 1.5.1.32 and 1.5.1.38 is highly specific and relies on knowing the exact substrate (FMNH2) for 1.5.1.38.",
    "The reviewer-only evidence was not available to the evaluated model; the reasoning argument relies solely on sequence motifs and general flavoprotein/chorismate synthase family knowledge."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "C6KT66",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "fe5eb10add0487313022107f5b8f7a01b13d2045fba1e86358f100bf68ffcc0d",
  "benchmark_sequence_length": 527,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 91,
    "firstPublicDate": "2025-06-18",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2009-09-01",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "b6ae207868ea88bb5964ba12c0f98a873e25a94ca43881742871c2ccf03a8e83",
  "current_source_sequence_sha256": "fe5eb10add0487313022107f5b8f7a01b13d2045fba1e86358f100bf68ffcc0d",
  "current_source_sequence_length": 527,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 89,
  "selected_historical_version": {
    "accession": "C6KT66",
    "database": "Swiss-Prot",
    "entryVersion": 89,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "AROC_PLAF7",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "a21a25bc44bf029252f986ed96532642a07f6208fc629be2d9c836438bd38e9b",
  "selected_historical_source_sequence_sha256": "fe5eb10add0487313022107f5b8f7a01b13d2045fba1e86358f100bf68ffcc0d",
  "selected_historical_source_sequence_length": 527,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 89,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/C6KT66.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/C6KT66.json",
  "source_sha256": "b6ae207868ea88bb5964ba12c0f98a873e25a94ca43881742871c2ccf03a8e83",
  "retrieved_utc": "2026-11-02T04:27:31.463877+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"C6KT66\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/C6KT66.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/C6KT66.json",
  "source_sha256": "b6ae207868ea88bb5964ba12c0f98a873e25a94ca43881742871c2ccf03a8e83",
  "retrieved_utc": "2026-11-02T04:27:31.463877+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":91,\"firstPublicDate\":\"2025-06-18\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2009-09-01\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/C6KT66.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/C6KT66.json",
  "source_sha256": "b6ae207868ea88bb5964ba12c0f98a873e25a94ca43881742871c2ccf03a8e83",
  "retrieved_utc": "2026-11-02T04:27:31.463877+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"evidences\":[{\"evidenceCode\":\"ECO:0000312\",\"id\":\"UP000001450\",\"source\":\"Proteomes\"}],\"lineage\":[\"Eukaryota\",\"Sar\",\"Alveolata\",\"Apicomplexa\",\"Aconoidasida\",\"Haemosporida\",\"Plasmodiidae\",\"Plasmodium\",\"Laverania\"],\"scientificName\":\"Plasmodium falciparum (isolate 3D7)\",\"taxonId\":36329}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/C6KT66.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/C6KT66.json",
  "source_sha256": "b6ae207868ea88bb5964ba12c0f98a873e25a94ca43881742871c2ccf03a8e83",
  "retrieved_utc": "2026-11-02T04:27:31.463877+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"31381947\",\"source\":\"PubMed\"}],\"value\":\"1.5.1.38\"},{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"11298276\",\"source\":\"PubMed\"},{\"evidenceCode\":\"ECO:0000269\",\"id\":\"31381947\",\"source\":\"PubMed\"}],\"value\":\"4.2.3.5\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"11298276\",\"source\":\"PubMed\"},{\"evidenceCode\":\"ECO:0000303\",\"id\":\"31381947\",\"source\":\"PubMed\"}],\"value\":\"Chorismate synthase\"},\"shortNames\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"11298276\",\"source\":\"PubMed\"}],\"value\":\"PfCS\"}]}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/C6KT66.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/C6KT66.json",
  "source_sha256": "b6ae207868ea88bb5964ba12c0f98a873e25a94ca43881742871c2ccf03a8e83",
  "retrieved_utc": "2026-11-02T04:27:31.463877+00:00",
  "json_pointer": "/comments/1",
  "excerpt": "{\"commentType\":\"CATALYTIC ACTIVITY\",\"physiologicalReactions\":[{\"directionType\":\"left-to-right\",\"evidences\":[{\"evidenceCode\":\"ECO:0000305\"}],\"reactionCrossReference\":{\"database\":\"Rhea\",\"id\":\"RHEA:21021\"}}],\"reaction\":{\"ecNumber\":\"4.2.3.5\",\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"11298276\",\"source\":\"PubMed\"},{\"evidenceCode\":\"ECO:0000269\",\"id\":\"31381947\",\"source\":\"PubMed\"}],\"name\":\"5-O-(1-carboxyvinyl)-3-phosphoshikimate = chorismate + phosphate\",\"reactionCrossReferences\":[{\"database\":\"Rhea\",\"id\":\"RHEA:21020\"},{\"database\":\"ChEBI\",\"id\":\"CHEBI:29748\"},{\"database\":\"ChEBI\",\"id\":\"CHEBI:43474\"},{\"database\":\"ChEBI\",\"id\":\"CHEBI:57701\"}]}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/C6KT66.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/C6KT66.json",
  "source_sha256": "b6ae207868ea88bb5964ba12c0f98a873e25a94ca43881742871c2ccf03a8e83",
  "retrieved_utc": "2026-11-02T04:27:31.463877+00:00",
  "json_pointer": "/comments/2",
  "excerpt": "{\"commentType\":\"CATALYTIC ACTIVITY\",\"physiologicalReactions\":[{\"directionType\":\"right-to-left\",\"evidences\":[{\"evidenceCode\":\"ECO:0000305\"}],\"reactionCrossReference\":{\"database\":\"Rhea\",\"id\":\"RHEA:21626\"}}],\"reaction\":{\"ecNumber\":\"1.5.1.38\",\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"31381947\",\"source\":\"PubMed\"}],\"name\":\"FMNH2 + NADP(+) = FMN + NADPH + 2 H(+)\",\"reactionCrossReferences\":[{\"database\":\"Rhea\",\"id\":\"RHEA:21624\"},{\"database\":\"ChEBI\",\"id\":\"CHEBI:15378\"},{\"database\":\"ChEBI\",\"id\":\"CHEBI:57618\"},{\"database\":\"ChEBI\",\"id\":\"CHEBI:57783\"},{\"database\":\"ChEBI\",\"id\":\"CHEBI:58210\"},{\"database\":\"ChEBI\",\"id\":\"CHEBI:58349\"}]}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C7

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/C6KT66.json)

```json
{
  "evidence_id": "C7",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/C6KT66.json",
  "source_sha256": "b6ae207868ea88bb5964ba12c0f98a873e25a94ca43881742871c2ccf03a8e83",
  "retrieved_utc": "2026-11-02T04:27:31.463877+00:00",
  "json_pointer": "/references/2",
  "excerpt": "{\"citation\":{\"authors\":[\"Fitzpatrick T.\",\"Ricken S.\",\"Lanzer M.\",\"Amrhein N.\",\"Macheroux P.\",\"Kappes B.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"11298276\"},{\"database\":\"DOI\",\"id\":\"10.1046/j.1365-2958.2001.02366.x\"}],\"citationType\":\"journal article\",\"firstPage\":\"65\",\"id\":\"11298276\",\"journal\":\"Mol. Microbiol.\",\"lastPage\":\"75\",\"publicationDate\":\"2001\",\"title\":\"Subcellular localization and characterization of chorismate synthase in the apicomplexan Plasmodium falciparum.\",\"volume\":\"40\"},\"evidences\":[{\"evidenceCode\":\"ECO:0000305\"}],\"referenceComments\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"11298276\",\"source\":\"PubMed\"}],\"type\":\"STRAIN\",\"value\":\"DD2\"}],\"referenceNumber\":3,\"referencePositions\":[\"FUNCTION\",\"CATALYTIC ACTIVITY\",\"SUBCELLULAR LOCATION\",\"DEVELOPMENTAL STAGE\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C8

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/C6KT66.json)

```json
{
  "evidence_id": "C8",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/C6KT66.json",
  "source_sha256": "b6ae207868ea88bb5964ba12c0f98a873e25a94ca43881742871c2ccf03a8e83",
  "retrieved_utc": "2026-11-02T04:27:31.463877+00:00",
  "json_pointer": "/references/3",
  "excerpt": "{\"citation\":{\"authors\":[\"Khera H.K.\",\"Singh S.K.\",\"Singh S.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"31381947\"},{\"database\":\"DOI\",\"id\":\"10.1016/j.molbiopara.2019.111202\"}],\"citationType\":\"journal article\",\"firstPage\":\"111202\",\"id\":\"31381947\",\"journal\":\"Mol. Biochem. Parasitol.\",\"lastPage\":\"111202\",\"publicationDate\":\"2019\",\"title\":\"Chorismate synthase from malaria parasites is bifunctional enzyme.\",\"volume\":\"233\"},\"evidences\":[{\"evidenceCode\":\"ECO:0000305\"}],\"referenceNumber\":4,\"referencePositions\":[\"FUNCTION\",\"CATALYTIC ACTIVITY\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/C6KT66?format=txt&versions=89)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/C6KT66?format=txt&versions=89",
  "source_sha256": "a21a25bc44bf029252f986ed96532642a07f6208fc629be2d9c836438bd38e9b",
  "retrieved_utc": "2026-11-02T04:27:34.407274+00:00",
  "source_locator": "lines 1-15",
  "excerpt": "ID   AROC_PLAF7              Reviewed;         527 AA.\nAC   C6KT66;\nDT   18-JUN-2025, integrated into UniProtKB/Swiss-Prot.\nDT   01-SEP-2009, sequence version 1.\nDT   28-JAN-2026, entry version 89.\nDE   RecName: Full=Chorismate synthase {ECO:0000303|PubMed:11298276, ECO:0000303|PubMed:31381947};\nDE            Short=PfCS {ECO:0000303|PubMed:11298276};\nDE            EC=1.5.1.38 {ECO:0000305|PubMed:31381947};\nDE            EC=4.2.3.5 {ECO:0000269|PubMed:11298276, ECO:0000269|PubMed:31381947};\nGN   Name=CS {ECO:0000305}; Synonyms=AROC {ECO:0000303|PubMed:11298276};\nGN   ORFNames=PF3D7_0623000 {ECO:0000312|EMBL:CAG25042.1};\nOS   Plasmodium falciparum (isolate 3D7).\nOC   Eukaryota; Sar; Alveolata; Apicomplexa; Aconoidasida; Haemosporida;\nOC   Plasmodiidae; Plasmodium; Plasmodium (Laverania).\nOX   NCBI_TaxID=36329 {ECO:0000312|Proteomes:UP000001450};\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 89,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/C6KT66?format=txt&versions=89)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/C6KT66?format=txt&versions=89",
  "source_sha256": "a21a25bc44bf029252f986ed96532642a07f6208fc629be2d9c836438bd38e9b",
  "retrieved_utc": "2026-11-02T04:27:34.407274+00:00",
  "source_locator": "lines 6-9",
  "excerpt": "DE   RecName: Full=Chorismate synthase {ECO:0000303|PubMed:11298276, ECO:0000303|PubMed:31381947};\nDE            Short=PfCS {ECO:0000303|PubMed:11298276};\nDE            EC=1.5.1.38 {ECO:0000305|PubMed:31381947};\nDE            EC=4.2.3.5 {ECO:0000269|PubMed:11298276, ECO:0000269|PubMed:31381947};\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 89,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/C6KT66?format=txt&versions=89)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/C6KT66?format=txt&versions=89",
  "source_sha256": "a21a25bc44bf029252f986ed96532642a07f6208fc629be2d9c836438bd38e9b",
  "retrieved_utc": "2026-11-02T04:27:34.407274+00:00",
  "source_locator": "lines 50-58",
  "excerpt": "RN   [3] {ECO:0000305}\nRP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND DEVELOPMENTAL\nRP   STAGE.\nRC   STRAIN=DD2 {ECO:0000303|PubMed:11298276};\nRX   PubMed=11298276; DOI=10.1046/j.1365-2958.2001.02366.x;\nRA   Fitzpatrick T., Ricken S., Lanzer M., Amrhein N., Macheroux P., Kappes B.;\nRT   \"Subcellular localization and characterization of chorismate synthase in\nRT   the apicomplexan Plasmodium falciparum.\";\nRL   Mol. Microbiol. 40:65-75(2001).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 89,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/C6KT66?format=txt&versions=89)

```json
{
  "evidence_id": "H4",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/C6KT66?format=txt&versions=89",
  "source_sha256": "a21a25bc44bf029252f986ed96532642a07f6208fc629be2d9c836438bd38e9b",
  "retrieved_utc": "2026-11-02T04:27:34.407274+00:00",
  "source_locator": "lines 59-64",
  "excerpt": "RN   [4] {ECO:0000305}\nRP   FUNCTION, AND CATALYTIC ACTIVITY.\nRX   PubMed=31381947; DOI=10.1016/j.molbiopara.2019.111202;\nRA   Khera H.K., Singh S.K., Singh S.;\nRT   \"Chorismate synthase from malaria parasites is bifunctional enzyme.\";\nRL   Mol. Biochem. Parasitol. 233:111202-111202(2019).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 89,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H5

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/C6KT66?format=txt&versions=89)

```json
{
  "evidence_id": "H5",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/C6KT66?format=txt&versions=89",
  "source_sha256": "a21a25bc44bf029252f986ed96532642a07f6208fc629be2d9c836438bd38e9b",
  "retrieved_utc": "2026-11-02T04:27:34.407274+00:00",
  "source_locator": "lines 72-78",
  "excerpt": "CC   -!- CATALYTIC ACTIVITY:\nCC       Reaction=5-O-(1-carboxyvinyl)-3-phosphoshikimate = chorismate +\nCC         phosphate; Xref=Rhea:RHEA:21020, ChEBI:CHEBI:29748,\nCC         ChEBI:CHEBI:43474, ChEBI:CHEBI:57701; EC=4.2.3.5;\nCC         Evidence={ECO:0000269|PubMed:11298276, ECO:0000269|PubMed:31381947};\nCC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:21021;\nCC         Evidence={ECO:0000305};\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 89,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H6

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/C6KT66?format=txt&versions=89)

```json
{
  "evidence_id": "H6",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/C6KT66?format=txt&versions=89",
  "source_sha256": "a21a25bc44bf029252f986ed96532642a07f6208fc629be2d9c836438bd38e9b",
  "retrieved_utc": "2026-11-02T04:27:34.407274+00:00",
  "source_locator": "lines 79-85",
  "excerpt": "CC   -!- CATALYTIC ACTIVITY:\nCC       Reaction=FMNH2 + NADP(+) = FMN + NADPH + 2 H(+); Xref=Rhea:RHEA:21624,\nCC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57618, ChEBI:CHEBI:57783,\nCC         ChEBI:CHEBI:58210, ChEBI:CHEBI:58349; EC=1.5.1.38;\nCC         Evidence={ECO:0000269|PubMed:31381947};\nCC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:21626;\nCC         Evidence={ECO:0000305};\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 89,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/EC_number.json), zero-based source row 48. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
